Amid intensifying scrutiny of pharmacy profit managers, a gaggle of Home Republicans is urging the U.S. Authorities Accountability Workplace to research the function these controversial middlemen play within the opaque pharmaceutical pricing system.
In a June 17 letter, the lawmakers cite more and more acquainted questions in regards to the interactions between pharmacy profit managers and drug corporations, business well being plans, state Medicaid applications, and pharmacies. At challenge are numerous rebates and charges that pharmacy profit managers cost, which critics say add to the price of prescribed drugs regardless of an absence of transparency.
Unlock this text by subscribing to STAT+ and revel in your first 30 days free!
